Powder: -20°C for 3 years | In solvent: -80°C for 1 year
KPLH1130, a specific pyruvate dehydrogenase kinase (PDK) inhibitor, enhances glucose tolerance in mice fed a high-fat diet (HFD). It effectively hinders macrophage polarization and mitigates proinflammatory reactions.
説明 | KPLH1130, a specific pyruvate dehydrogenase kinase (PDK) inhibitor, enhances glucose tolerance in mice fed a high-fat diet (HFD). It effectively hinders macrophage polarization and mitigates proinflammatory reactions. |
分子量 | 283.28 |
分子式 | C15H13N3O3 |
CAS No. | 906669-07-6 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 130 mg/mL (458.91 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
KPLH1130 906669-07-6 Metabolism PI3K/Akt/mTOR signaling PDK Dehydrogenase KPLH 1130 Pyruvate dehydrogenase kinase PDH kinase KPLH-1130 inhibit Inhibitor PDHK inhibitor